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OUTLINE 
Name: Shanice Clarke 
Section: 1 
My topic: Bifidobacterium 
I am very intrigue about microorganism and their association with living and non-living 
organism. I decided to research this topic because I want to become a microbiologist in the 
future. I am especially interested with the impact of Bifidobacterium longum/infantis on infants. 
Outline: 
Abstract 
Keywords 
Introduction 
Topic 1 
     The impact of Bifidobacterium longum/infantis on infants’ gastrointestinal tract 
         - B. infantis is the only Bifidobacterium that can digest HMOs in human milk 
          - B. infantis reduce dysbiosis condition in infants 
           - B. infantis limit the colonization of other harmful bacteria in infant 
Topic 2 
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ABSTRACT 
      This review focuses on the impact of Bifidobacterium longum/infantis on infants and to 
associate these impacts to effect of B. longum/infantis on the titers of polio IgA in infants. 
 Bifidobacterium longum/infantis is a ubiquitous inhabitant of the gastrointestinal tract of infants; 
these bacteria are the champion colonizer of the gastrointestinal tract blocking out other harmful 
bacteria from colonizing. B. longum/infantis have been shown to improve dysbiosis condition 
and prevent infants from getting any allergy or harmful disease such as poliomyelitis. This 
review was aimed to assess the impact B. longum/B. infantis has on infants and to associate these 
impacts to the effect B. longum/B. infantis has on polio titers after vaccination. Researchers have 
determined that infants who were fed with a fermented formula versus infants who were fed with 
a placebo that the B. longum/B. infantis that was present in the stool of the infants was 
significantly different from the placebo group (0.0399, fisher exact test). There is a positive 
correlation between B. longum/B. infantis with anti-poliovirus. 
 
Keywords 
Bifidobacterium longum 
Bifidobacterium infantis 
Poliomyelitis  
Human Milk Oligosaccharides- HMOs 
Immunoglobulin  
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INTRODUCTION 
  Bifidobacterium, member of the Actinobacteria phylum, is a genus of gram-positive bacteria 
that is anaerobic and a ubiquitous inhabitant of the gastrointestinal tract. B. longum subspecies 
infantis is a species of bacteria within the genus of Bifidobacterium that is found in the 
microbiota of infant’s gastrointestinal tract and is associated with health benefits for infants. 
Infants that have  high levels of B. longum/infantis in their system tend to have an enhance 
immune response to viruses such as polio and tend to be a good component for human milk 
degradation. Infants that was born through C-section tend to have less B. infantis in their system 
and must rely on breast milk or fermented milk to obtain the bacteria that can help prevent 
numerous illness in infant that is colonize by the bacteria. B. longum/infantis is prominent in 
infants that is breast fed or fed with a fermented formula which coincide with the increase in 
antibodies titers of polio viruses (2).                 
         Infants that have lower levels of B. longum/infantis are more likely to suffer from allergies 
and is more susceptible to infections (2,8). Interestingly, mothers with allergies have 
significantly lower levels of several different species of Bifidobacterium in their breast milk (5). 
Polio virus cases is steadily increased 5-10 percent in children in the United States. This review 
focuses on the impact of Bifidobacterium longum/infantis on infants and to associate these 
impacts to effect of B. longum/infantis on the titers of polio IgA in infants. 
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The impact of Bifidobacterium longum/infantis on infants’ 
gastrointestinal tract 
 
    Bifidobacterium infantis is a subspecies of B. longum; this species of Bifidobacteria are 
mainly found colonizing the gastrointestinal tract of infants, and the older infants get the lower 
the levels of B. longum/B.infantis (2). This may be a result because B. longum/B.infantis plays a 
very vital role in the breakdown of human milk (9). The older one gets the more their diet move 
from solely consuming human milk to being more diverse. B. longum/B.infantis is a ubiquitous 
inhabitant so they crowd the gastrointestinal tract of infants that can potentially block out other 
harmful bacteria from colonizing the gastrointestinal tract (8). The presence of Bifidobacterium 
longum/infantis in the gastrointestinal tract of infants will have positive impacts on the infant’s 
gut microbiota. 
 B. infantis is the only Bifidobacterium that can digest HMOs in human milk 
          Human Milk Oligosaccharides (HMOs) is a solid component found in human breast milk. 
HMOs are complex carbohydrates that infants cannot digest, because the human gut does not 
have the required enzymes to cleave the linkage between HMO molecules (8). There was an 
uncertainty of the importance of HMOs to infants, since humans cannot digest these molecules, 
until studies linked these HMOs to B. infantis (8). B. infantis have a gene called HMO cluster 1 
that allows it to grow on a medium that contains HMOs more than any other form of 
Bifidobacteria (8), and can cleave HMOs and deconstruct human milk glycan (8). Underwood 
and German (8) concluded that infants that were colonized by B. infantis not only can 
deconstruct human milk, but can also out compete other Bifidobacteria and other pathogenic 
bacteria in the gut lumen of breast-fed milk. Premature infants did not have any species of 
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Bifidobacteria, but had a diversity of other bacteria, and premature infants were more 
susceptible to Necrotizing enterocolitis (NEC) which is a dysbiosis condition (8). Dysbiosis is 
an imbalance between the type of organisms present in one’s natural microflora.  Probiotics is 
a possible treatment for premature infants, because it contains B. infantis and will decrease 
NEC in infants (8). 
                           B. infantis reduce dysbiosis condition in infants 
        Dysbiosis is a condition characterized by the imbalance between the bacteria that is good 
for you and the bacteria that is bad for you. The development of infant’s gut microbiota at the 
beginning stage of their life will play a vital role in the long-term health of the infant (8). 
Probiotics has been a treatment option to correct the imbalance of bacteria in the body (8, 10). 
It has proven that probiotics that have B. infantis would lead to persistent colonization of 
infants that were breast fed, which will eventually change the composition of the gut 
microbiota (8). Infants guts whose colonized by B. longum/B.infantis showed higher levels of 
Antipoliovirus IgAs when vaccinated with polio virus (2). This may be a result of the fact that 
B. infantis is a ubiquitous inhabitant crowding the gut microbiota blocking out other harmful 
bacteria from colonizing. (Frese, 2017) In conclusion, infants fed with B. infantis had 
increased levels of B. infantis in their gut microbiota and fecal microbiota. The infants that 
were not fed with any probiotics did not have any Bifidobacteria growing in their microbiota 
(10). Thirty days after infants were treated with B. infantis; the bacteria were still present in 
the gut microbiota and was one of the major colonizers of the gut (10). This may be a result of 
the gene that B. infantis have adapted to cleave HMOs, infants’ diet is mainly consisting of 
milk and it has been proven no other species of Bifidobacterium can digest the HMOs. The 
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presence of B. infantis have many positive impacts on infant’s gut microbiota, making it a 
friendly bacterium; this is a bacterium that one would like their child to have. 
         B. infantis limit the colonization of other harmful bacteria in infant 
        Infants obtain B. longum/B.infantis when they are born through the vagina or skin when 
being delivered via C-section. These bacteria are present in the gut microbiota of the infant after 
delivery, but they are not activated. Breast milk activates the Bifidobacterium to start colonizing 
the gastrointestinal tract of infants.  B. longum/B.infantis can change the fecal component of 
infants which will in turn prevent diarrhea (2). The levels of B. infantis are lower in infants that 
are delivered via C-section since the infant would not be exposed to as much Bifidobacteria 
through delivery (2). Babies from more developed countries experience more dysbiosis condition 
than those babies from less developed countries. This might be explained because C-section 
delivery is not common in underdeveloped countries, and most infants delivered vaginally will 
be more exposed to Bifidobacterium longum/ infantis stabilizing the colonization of the gut 
microbiota (2). 
            Higher levels of B. longum/B.infantis have a positive impact on infants; B. infantis is the 
only species of Bifidobacterium that can digest HMOs which prove helpful in human milk 
degradation and B. longum/B.infantis plays a vital role in treating NEC (8). Lower level of B. 
longum/ infantis have a negative impact on infant’s gut microbiota, this is because other bacteria 
may colonize the infants gut microbiota that may be harmful to the infant and infants that have 
lower levels of B. longum/B.infantis are more susceptible of having dysbiosis condition (2, 8).   
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The immunological response of high level of B. 
longum/infantis to polio titers in infants 
 
     Poliomyelitis, also called polio, is a disease that can affect both adults and infants. Polio 
viruses can enter the body through the mouth, by hands or other body parts that have come in 
contact with the feces of someone who has the polio virus. In order to prevent from getting the 
polio virus, a polio vaccine was created and is recommended and sometimes required. Infants 
that are predominantly colonized by B. longum/B. infantis correlate with higher levels of polio 
titers when vaccinated with the polio vaccine (2, 11). Stool from infants with high levels of polio 
titers had higher levels of B. longum/B. infantis (2, 11). Higher levels of Bifidobacterium longum 
subspecies infantis and also longum will have a positive association with polio titers in infants. 
Bifidobacterium (especially B. longum subspecies infantis) increase response to 
oral polio virus vaccine early in infant’s life. 
         Immunization prevent infants and adults from getting infectious diseases such as 
poliomyelitis. Studies have analyzed the association between vaccine responses and levels of 
bacteria find in infants’ stool. For example, another member of the Actinobacteria phylum have a 
positive association with oral polio virus specific T-cell proliferation and oral polio virus specific 
immunoglobulin G responses (11). Also, infants with higher Oral Polio Virus CD4 molecule 
responder also had higher levels of B. longum/B. infantis (11). CD4 molecules are a type of T-
cell helper; which are proteins on antibodies that come in contact with antigens to produce an 
immune response when the body encounter an antigen. Infants with higher level of Oral Polio 
Virus CD8 molecule responder also had higher-levels of B. longum (11). Interestingly, stools 
from those infants with high Oral Polio Virus vaccine responses, were predominantly colonized 
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by B. longum subspecies infantis (11). This result, indicated that the gut composition of the 
microbiota of infants may play a vital role in which the infant’s immune system may interact 
with oral or parental vaccines, because high levels of B. longum/ B. infantis result in increased 
immunological response to vaccines (11). In fact, infants that have a more diverse gut microbiota 
(and less Bifidobacteria) have lower responses to vaccines and may suffer from systematic 
inflammation (11). 
Secretory IgA in breast milk protects newborns from all infection 
      Breast milk is said to protect newborns from infection (2). Infants obtain B. longum/ B. 
infantis when they are born (2, 8), breast milk is what activates the bacteria. Once activated, 
Bifidobacteria will colonize the infant’s gastrointestinal tract (2). Breast milk also contains 
secretory immunoglobulin titers; which are antibodies that serve as the first line of defense 
against antigens (2). Therefore, infants that were breast fed immune system prime sooner than 
infants that were not breast fed. Colonization by Bifidobacteria, mainly B. longum/B. infantis, 
can trigger an immune response in infants (2). In order to test if the gut microbiota can trigger an 
immune response, there was a study carried out with inactivated poliovirus vaccine to determine 
if there is an increase in the fecal immunoglobulin A titers before and after vaccination (2). 
Infants were either fed with fermented formula or placebo. Both groups had an increase in the 
levels of B. longum/B. infantis in the infant’s feces, but the group that was treated with the 
fermented formula had higher levels than the placebo (2). There was also a correlation between 
the increased polio specific intestinal antibody response to higher levels of B.longum/B.infantis 
in infants that were fed with fermented formula (2). Infants that were fed with fermented formula 
(FIF) have a higher level of fecal bifidobacterial the longer they were being treated, which may 
result in those infants having an increase in the Anti-poliovirus IgA titers (2,11). Fermented 
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formula can trigger an Anti-poliovirus response which in turn favors intestinal Bifidobacteria in 
infants (2).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
11 
 
CONCLUSION 
 
    This review focuses on the impact of Bifidobacterium longum/infantis on infants and to 
associate these impacts to effect of B. longum/infantis on the titers of polio IgA in infants. Based 
on the results gathered from each peer-reviewed article it is safe to say Bifidobacterium 
longum/infantis is a friendly bacterium that you would want your child to have. B. longum/B. 
infantis helps protect infants from dysbiosis and diseases including poliomyelitis. B. infantis is 
the only bacteria that can digest HMOs which is very crucial for infants.  B. longum/B. infantis is 
more prominent in infants and are associated with higher levels of polio IgA titers when 
vaccinated with the polio vaccine; infants that have lower levels of anti-poliovirus titers also 
have lower levels of B. longum/B. infantis in their feces. Furthermore, infants who have higher 
levels of anti-poliovirus titers also have higher levels of B. longum/B. infantis in their feces, 
which indicates that there is a positive correlation between anti-poliovirus IgA and B. longum/B. 
infantis. 
       It was determined that higher levels of B. longum/infantis will be present in infants that were 
fed with infant fermented formula and those infants also have a higher level of antipoliovirus 
titers. I accept the results that were determined in the peer-reviewed and I believe that there will 
be a positive correlation with antipoliovirus titers and the levels of B. longum/infantis in infants 
that was fed with fermented formula. 
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